Елтромбопаг Тева

Eltrombopag Teva is an oral medication used to support platelet production in adults and children with certain blood conditions. This EU-manufactured treatment helps manage low platelet counts safely and effectively. Suitable for those seeking reliable blood health support.

Eltrombopag Teva is primarily used to increase platelet counts in people with chronic immune thrombocytopenia (ITP), a condition where the immune system attacks platelets. It may also be prescribed for patients with hepatitis C-related low platelet counts to help them undergo interferon treatment safely. The medication works by stimulating the bone marrow to produce more platelets.

Many patients notice an improvement in their platelet levels within weeks of starting Eltrombopag Teva. Common effects include a gradual rise in energy and reduced bruising or bleeding tendencies. Some users report mild digestive discomfort, such as nausea or stomach upset, especially when first taking the medication.

Eltrombopag Teva should be taken on an empty stomach, ideally one hour before or two hours after a meal, to ensure proper absorption. Regular blood tests are important to monitor platelet levels and liver function during treatment. Avoid taking calcium-rich foods or supplements within four hours of your dose to prevent interference with absorption.

Certain medications, including antacids, dairy products, and supplements containing calcium or iron, can reduce the effectiveness of Eltrombopag Teva. It may also interact with drugs that affect liver enzymes, such as some statins or antifungals. Always inform your healthcare provider about all medications and supplements you are taking before starting this treatment.